Kyowa Hakko Kirin | 4151
Stock Price
2,067.50
Daily Change
30.00 1.47%
Monthly
-9.62%
Yearly
-28.06%
Q1 Forecast
2,254.34



Peers Price Chg Day Year Date
M3 2,012.00 61.00 3.13% -1.61% Feb/21
Kyowa Hakko Kirin 2,067.50 30.00 1.47% -28.06% Feb/21
Takeda 4,214.00 53.00 1.27% -4.96% Feb/21
Astellas Pharma 1,468.00 14.50 1.00% -11.00% Feb/21
Sumitomo Dainippon 774.00 7.00 0.91% 121.78% Feb/21
Shionogi 2,257.00 59.00 2.68% -68.42% Feb/21
Chugai Pharma 7,696.00 340.00 4.62% 36.26% Feb/21
Eisai 4,283.00 41.00 0.97% -30.46% Feb/21
Terumo 2,669.00 -14.00 -0.52% -53.45% Feb/21
Daiichi Sankyo 3,442.00 25.00 0.73% -30.00% Feb/21
Otsuka Holdings 7,171.00 39.00 0.55% 27.19% Feb/21
Indivior 695.50 -36.50 -4.99% -48.71% Feb/21

Indexes Price Day Year Date
JP225 38508 98.90 0.26% -1.51% Feb/21

Kyowa Hakko Kirin traded at 2,067.50 this Friday February 21st, increasing 30.00 or 1.47 percent since the previous trading session. Looking back, over the last four weeks, Kyowa Hakko Kirin gained 9.62 percent. Over the last 12 months, its price fell by 28.06 percent. Looking ahead, we forecast Kyowa Hakko Kirin to be priced at 2,254.34 by the end of this quarter and at 2,068.32 in one year, according to Trading Economics global macro models projections and analysts expectations.

Kyowa Kirin Co., Ltd., formerly Kyowa Hakko Kirin Co., Ltd. is a Japan-based company principally engaged in the manufacture and sale of medical drugs. The Company operates through two business segments. Pharmaceuticals segment conducts research, development, manufacture and sale of pharmaceuticals and other products. Bio-chemicals segment is involved in the research, development, manufacture and sale of pharmaceuticals and industrial raw materials mainly for amino acid and nucleic acid related substances, as well as healthcare products.